To discuss and review the role for elective treatment of the neck in maxillary squamous cell carcinoma. Improvements in survival have been seen because of improved local therapies and control; therefore, the treatment of the neck has become a topic of debate.
INTRODUCTION
Primary malignant tumors of the sinonasal tract are rare. They account for less than 10% of head and neck cancers with an annual incidence of 0.5-1.0/ 100 000 people in the United States [1] . The maxillary sinus is the second most common subsite, preceded only by the nasal cavity for neoplasia of epithelial origin arising in this area. Squamous cell carcinoma (SCC) is by far the most prevalent malignant histology, accounting for 57-80% of all malignant tumors. This is followed by minor salivary gland tumors, sarcoma, esthesioneuroblastoma, lymphoma, sinonasal undifferentiated carcinoma, and melanoma, which occur in decreasing frequency. As in the remainder of the head and neck region, smoking predisposes one to SCC. SCC can also arise from inverting papillomas in 10% of cases and rarely in the background of chronic sinusitis. More unique risk factors however are exposure to wood dust, chemicals such as chromium, nickel, and formaldehyde, which are associated with other malignant tumors, such as adenocarcinoma and clear cell carcinoma [2] . PRESENTATION Neoplasms of maxillary sinus or antrum of Highmore rarely present with symptoms at an early stage ( Fig. 1 ) as many lesions are asymptomatic until they become quite large [1] . Symptoms of obstruction or local invasion of adjacent tissue (soft tissue mass, loose teeth, anesthesia of V2, diplopia, proptosis, and trismus) are often the first presenting sign. As such, 82% of patients present with advanced stage of disease (T3 or higher) ( Table 1 ) [1] . However, even with advanced T stage, it is thought that the incidence of nodal metastasis is low, as the maxillary sinus does not have an extensive lymphatic drainage network [3] .
In the 1930s, Ö hngren described an imaginary plane defined by a line joining the medial canthus of the eye to the angle of the mandible. This plane divides the region of the nasal cavity and maxillary sinus into half: the infrastructure (anteroinferior) and suprastructure (posterosuperior) (Fig. 2 ). This line was to delineate the easily resectable tumors of the infrastructure, from the more difficult, and harder to cure, tumors of the suprastructure. Tumors of the infrastructure of the maxillary antrum may extend through the floor of the antrum into the oral cavity, through the medial wall into the nasal cavity, and through the anterior wall to the soft tissues of the cheek or through the lateral wall into the masticator space. Lesions involving the suprastructure spread by extension through the posterior wall into the pterygomaxillary space, pterygopalatine fossa, infratemporal fossa, and the middle cranial fossa; through the roof of the sinus into the orbit; or via the ethmoid cavities to the anterior cranial fossa ( Fig. 3 ). Tumors may also track along the infraorbital nerve to the Gasserian ganglion [4] . Tumors of the infrastructure generally produce symptoms early, and thus present at an earlier stage, and are more readily amenable to a satisfactory resection with an excellent chance for local control than lesions of the suprastructure.
LYMPHATIC DRAINAGE OF THE MAXILLARY SINUS
The maxillary sinus is thought to be an area with paucity of lymphatic pathways with two main routes of lymphatic drainage: the ipsilateral jugulodigastric nodes and the retropharyngeal nodes. One drainage pathway runs from the maxillary gingiva to the submandibular nodes (level 1) through the buccal lymphatic vessels or buccinator nodes. The second pathway runs from the nasal floor to the upper jugular nodes through the retropharyngeal or parapharyngeal nodes [5, 6] . Therefore, the majority of observed nodal involvement occurs in level 1 and 2 [3, 7] . A review of T4 maxillary sinus SCC patients by Homma et al. 
KEY POINTS
Treatment failure occurs in 62% of all patients, with local recurrence by far the most common site of treatment failure in any stage; local failure is rarely amenable to salvage therapy.
Most cervical relapse is accompanied with uncontrollable primary or distant relapse, explaining the poor survival of those with cervical relapse.
Patients with cervical relapse alone can be salvaged in 50-70% of cases.
Aggressive therapy to achieve maximum local control of the primary tumor is considered to be more important than elective neck treatment.
Elective treatment of the neck can only be considered justifiable in patients with advanced-stage primary carcinomas (T3-4) of the maxillary sinus. Very advanced local disease. Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve (V 2 ), nasopharynx, or clivus those with cervical metastases at the time of diagnosis, 96% had ipsilateral level 1b or 2 disease. However, the retropharyngeal lymph nodes, level 3, level 4, and contralateral neck can also be involved in a minority of patients, particularly those with advanced-stage primary tumors, and those tumors that cross the midline (Fig. 4 ). This is in keeping with an earlier review by Yagi et al. [9] , who when looking at all stages and histology of tumors arising in the maxillary sinus, noted that cervical metastatic disease was most commonly found in the ipsilateral upper jugular region, followed by the submandibular region and then the lower jugular region. Less frequently, bilateral disease was seen. Also, retropharyngeal node involvement has been reported in 7-16% [6,8 & ,10] of patients at the time of diagnosis, as well in those developing regional failures [11] .
ELECTIVE MANAGEMENT OF THE NECK IN MAXILLARY CANCER
As a result of the limited lymphatic drainage and rarity of regional disease at presentation, a topic of continued debate remains in regards to how best to treat the N0 neck. Many articles have been published on this topic, including more recent reviews and a meta-analysis, underscoring the continued uncertainty and debate [2, 5, 7 
The current 2013 National Comprehensive Cancer Network guidelines recommend adjuvant radiation therapy to the N0 neck in the setting of T3 and T4a disease. However, for smaller primary lesions (T1 and T2), no elective treatment of the neck is recommended. Most data on this topic consist of small series, with multiple histologies and multiple subsites, treated over a broad span of time with changing treatment patterns making interpretation difficult. It is accepted that different histologies have different propensities for nodal spread ( Table 2 ) and as such, the risk of metastases changes based on tumor histology. Nodal metastases have been reported in as high as 28% of patients with SCC, 25% for adenocarcinoma, 12% for undifferentiated carcinoma, and 10% for adenoid cystic carcinoma [20] . Another review has the incidence of lymph node involvement in nonsquamous cell carcinoma of the maxillary sinus at presentation even lower (in the range of 3-6%) [21, 22] .
In this review, we are focusing on SCC as it is the most common histology and appears to be the most aggressive in regards to nodal metastasis. In the literature, the rate of involvement of regional lymph nodes, for SCC varies widely. Le et al. [3] reports an overall incidence of lymph node involvement at diagnosis of 15.5% when only SCC histology is taken into account. This is consistent with many reports [5, 7, 9, 12, 13, [23] [24] [25] and because of this low number most authors have advocated no elective neck treatment for patients with maxillary sinus carcinoma. However, in the 1990s, Paulino et al. [7] and Jiang et al. [21] began to advocate elective ipsilateral neck irradiation in all patients with SCC because of high incidence of neck relapse associated with SCC histology (28-36% in their respective reviews) and the poor prognosis of those who relapsed in the neck [7, 21, 26] . A review of the literature, however, shows regional failure in the N0 neck to be significantly lower at 4 [24] to 17% [14] , especially when looking at patients who did not have synchronous local failure [9, 27] (Table 3 ).
In an attempt to address the rate of nodal failure, one article in the literature focused on the use of elective neck dissection in the management of SCC of the maxillary sinus. In a series by Brown et al. [15 & ], 13 patients with N0 necks underwent elective neck dissection. Even after neck dissection, they had two neck recurrences in the ipsilateral dissected neck. This 15% (2/13) is consistent with their and our review of the literature of isolated neck recurrences in the nontreated neck (12%, range 5-36%) [15 & ]. This is the only article describing elective neck dissection in this patient population. One reason for this is that surgical clearance of the retropharyngeal nodal basin, that likely is at risk of occult nodal disease, is not possible. Therefore, most other studies and the National Comprehensive Cancer Network guidelines focus on elective irradiation to the neck in advanced tumors as irradiation to the ipsilateral upper jugular lymph nodes is not thought to bring about much additional morbidity and is well tolerated by the patient.
It is suggested that lesions that invade the hard palate, and present in the oral cavity, have a higher rate of nodal failure. This is due to the rich lymphatic pathways of the palate, and therefore they act more as an oral cavity primarily rather than maxillary sinus tumor [5,8 & ,13,15 & ,28,29] . In a series of 156 patients with SCC of the maxillary sinus by Cantu et al. [12] , 16 patients (10%) had regional recurrence, 11 of which (68.7%) were T2 N0 at Overall 601 100 52 25 35 Adapted with permission from [25] . presentation. In addition, T4 lesions with extension to the hard palate have been reported to have a significantly decreased local control rate, as compared with all T4 maxillary sinus tumors [30, 31] . A recent review of maxillary SCC originating in the oral cavity noted 38% [16 & ] of patients with cervical metastases at diagnosis, of which 33% (17/52) had N2c disease. These lesions originated in the hard palate, and thus were not truly maxillary sinus cancers, and support the existing theory that there is increased drainage and lymphatic spread from the oral cavity as compared with the maxillary sinus
Although the true rate of nodal metastases at presentation and subsequent nodal failure in the untreated neck has been the recent topic of discussion, it is noted in these studies that local recurrence is still the most common cause of treatment failure, with a very morbid course, and low salvage rates. Giri et al. [26] in 1992 noted that 49% (18/37) of their patients had a treatment failure with local recurrence as the most common site of failure in 16 of the 18 cases. In contrast, only three patients (8%) who were originally N0 and received no elective treatment of the neck developed cervical metastases. Two of the three of these recurrences also had recurrence at the primary site. As a result of the frequency of local failure, routine neck irradiation was not recommended as the added morbidity of radiation did not overweigh the small risk of having isolated neck failure. Kim et al. [13] also reported a local failure rate of 68.1% as compared with a regional failure rate of 19% during follow-up (median, 6 years) of their patients.
Our review of the literature (Table 4 ) and Memorial Sloan Kettering Cancer Center data ( Fig. 5) show an overall recurrence rate of 44-68%. Local recurrence in each study was most common, accounting for 43-75% of all recurrences. Nodal failure occurred less often, occurring in 8-33% of all failures. Isolated nodal failure was observed in 4.8 [24] to 7.3% [17 & ] of all patients when the primary site was controlled. Isolated neck failure accounted for 38-82% of all the cervical failures. The rate of isolated neck failure is similar to the rate of patients with distant failures [24] . In the largest series published, Cantu et al. [12] reported 31 isolated neck failures out of 230 recurrences in 399 maxillary sinus cancer. Of these, 30 (97%) were able to be surgically salvaged and only two died as a result of isolated neck metastasis [12] . Similarly, Dirix et al. [33] and Porceddu et al. [34] reported the salvageability of Table 3 . Incidence of nodal disease at presentation and after treatment [2,3,5,7,8 & ,9,12-14,21,24-27] isolated neck failures. These isolated failures occurred in the ipsilateral level 1b and 2 and as such allowed for identification and appropriate intervention. The occurrence of retropharyngeal nodes and overall medical status were the limiting factors keeping isolated nodal recurrences from being surgically salvaged. Although neck disease is able to be salvaged >50% of the time, recurrent local disease is extremely morbid and only 8 [9, 32] to 20% [9] of isolated local failures are salvaged. Local failure is the most common cause of death in these patients [32] . Le et al. [3] and Guan et al. [11] had patients, originally N0, who underwent elective neck irradiation (ENI) to the retropharyngeal and cervical nodes. Though both were small series (n ¼ 25 and 11, respectively), none of the patients who received ENI developed nodal metastasis. However, 10 [3] and 18% [11] of those who did not receive ENI suffered neck failures. Therefore, they support the use of elective irradiation to the ipsilateral level 1b and 2a during primary treatment, as there are few critical adjacent structures so late complications related to ENI of these echelons would be rare. Jiang et al. [21] looked at the survival for those who underwent ENI compared with those who had recurrence in the neck that were able to be salvaged. The 10-year disease-specific survival (DSS) was 34% in those with no ENI and 58% in those who received ENI. Based on this, MD Anderson changed their treatment practice to irradiate the neck in T2-4 SCC or undifferentiated maxillary sinus carcinoma [21] .
SURVIVAL
Over the past decades, better imaging assessments of the primary tumor have allowed adequate surgery and adjuvant therapies leading to improved local control [24, 25, 35] . Thus, attention is now focused to metastatic disease and survival. In the review by Takes et al. [18 & ], median survival of patients who remained N0 was 80 months, whereas those with any cervical involvement was 25 months (P ¼ 0.05). This is similar to the reviews by Wu et al. [35] and Kim et al. [13] that noted how node involvement at Table 4 . Recurrence patterns after primary treatment [3,5,7,9,11,13,14,15 & ,22,25-27,32] presentation affected survival. The 5-year survival rate with negative nodes was 31.3 [12] to 55% [36] , whereas for those with positive nodes it was 16.7 [12] to 17% [36] (P ¼ 0.03). Le et al. [3] also reported that patients with nodal relapse had a significantly higher risk of distant metastasis based on univariate (P ¼ 0.02) and multivariate analyses (HR ¼ 4.5, P ¼ 0.006) [2] ; with the 5-year actuarial risk of distant relapse being 29% for patients with neck control as compared with 81% for patients with neck failure [3] . However, the most powerful prognostic factor for overall survival remained T stage [25, 29] (P ¼ 0.026) [35] followed by nodal involvement (P ¼ 0.036) [35] . Therefore, although the presence of nodal relapse has been associated with decreased survival, it is rarely the cause of death. ]; however, it is unclear whether this improved regional control impacted on survival.
CONCLUSION
A majority of patients with malignant tumors of the maxillary sinus presented at an advanced T stage, which directly affects survival ( Figs. 6 and 7) . Treatment failure occurs in 62% of all patients, with local recurrence by far the most common site of treatment failure, which is rarely amenable to salvage therapy [24,37 & ,38,39]. Regional failure is less common and occurs in only 3-20% of all treated patients. Most cervical relapse is accompanied with uncontrollable primary or distant relapse, explaining the poor survival of those with cervical relapse. Patients with cervical relapse alone can be salvaged in 50-70% of cases [29] . Local failure is the primary cause of failure in any stage [29] , and as such, aggressive therapy to achieve maximum local control of the primary tumor is considered to be more important than elective neck treatment [13] . Thus, based on our own experience, elective treatment of the neck can only be considered justifiable in patients with advanced-stage primary carcinomas (T3-4) of the maxillary sinus. If the neck on the ipsilateral side is entered for example, to accomplish vascular anastomosis of a free flap, then elective neck dissection is performed at that time. If the neck is not entered, then elective irradiation of the neck, in conjunction with postoperative radiation therapy to the primary site, is recommended for T 3-4 tumors. Elective treatment of the neck in early-stage tumors (T 1-2) is not recommended. 
